Asthma
What the FAA's documents say about asthma, in plain words, with the FAA's own words one press away.
Short version
The Asthma Disposition Table sorts asthma into three rows.
| Situation | What the examiner does | Pathway |
|---|---|---|
| Row AResolved, an avoidable trigger, or exercise-induced | Examiner issues | Examiner can issue |
| Row BIntermittent or mild persistent asthma. | Worksheet | CACI |
| Row CModerate or severe persistent asthma. | Defers to the FAA | Special Issuance |
Show the FAA's words: the FAA's table for Asthma
- Row A · Examiner can issue
A history of childhood asthma that has resolved, asthma caused by a specific and avoidable trigger managed by avoidance and use of as needed (PRN) rescue inhaler, or exercise-induced bronchoconstriction (exercise-induced asthma) treated with as needed (PRN) rescue inhaler only. If the examiner can determine the pilot has no symptoms that would interfere with flight or safety related duties, the examiner issues and annotates this information in Block 60.
History of childhood asthma, resolved OR Asthma caused by a specific and avoidable trigger (e.g. exposure to pet or animal dander, specific foods etc.) managed by avoidance and use of as needed (PRN) rescue inhaler OR Exercise-induced bronchoconstriction (a.k.a. exercise-induced asthma), treated with as needed (PRN) rescue inhaler only … If the AME can determine the individual has no symptoms that would interfere with flight or safety related duties: ISSUE … Annotate this information in Block 60.
- Row B · CACI
Intermittent or mild persistent asthma. The table sends the examiner to the CACI worksheet for asthma, and says this requires a current, detailed clinical progress note and spirometry (a breathing test). The worksheet itself says spirometry is not required if the only treatment is PRN use on one or two days a week of a short-acting beta agonist (e.g., albuterol). The examiner issues with no time limitation when the pilot meets every criterion on the worksheet and is otherwise qualified, annotates the correct CACI statement in Block 60, and keeps the required supporting information on file.
Intermittent or mild persistent … See the CACI -Asthma Worksheet. This requires a current, detailed Clinical Progress Note and spirometry. … If the pilot meets all CACI worksheet criteria and is otherwise qualified, ISSUE With no time limitation … Annotate the correct CACI statement in Block 60 and keep the required supporting information on file.
Spirometry is not required if the only treatment is PRN use on one or two days a week of a short-acting beta agonist (e.g., albuterol).
- Row C · Special Issuance
Moderate or severe persistent asthma. The examiner defers and sends the listed information to the FAA for a possible Special Issuance, and annotates the elements or findings in Item 60.
Moderate or Severe persistent … Submit the following for FAA review: … DEFER Submit the information to the FAA for a possible Special Issuance … Annotate (elements or findings) in Item 60.
- A note on the table, 1
The AASI sheet notes that if the pilot has mild symptoms that are infrequent, have not required hospitalization or use of steroid medication, and no symptoms in flight, the examiner may issue an airman medical certificate. If the pilot does not meet those criteria, the sheet says the examiner must follow the AASI process.
Note: If the applicant has mild symptoms that are infrequent, have not required hospitalization, or use of steroid medication, and no symptoms in flight, the AME may issue an airman medical certificate. … If the applicant does not meet the above criteria, the AME must follow the AASI process.
The FAA pathways for asthma
- How this pathway works: Examiner can issueNo special pathwayRow A
- How this pathway works: CACIConditions AMEs Can IssueRow B
- How this pathway works: Special IssuanceAuthorization for Special Issuance of a Medical CertificateRow C
- How this pathway works: AASIAME Assisted Special IssuanceAfter the FAA decides
Which exam
Which one describes yours?
The FAA's table sorts it these ways. Choose yours to see its plan.
Your step-by-step plan
Step 1: Progress note from the treating doctor or specialist
The note the examiner must review, and the worksheet's criteria for your asthma.Within 90 days before the examA current, detailed progress note from a clinic visit with your treating physician or specialist, no more than 90 days before the exam. Your AME reviews it.
What your treating physician finds
- Stable on the current treatment, with no changes recommended
- Symptoms stable and well controlled, on or off medication
The limits
- 2 a week or fewer
- 2 times a week or fewer
- 2 times a year or fewer
- None
- 2 or fewer, fully resolved
Show the FAA's words: Progress note from the treating doctor or specialist
the AME must review a current, detailed Clinical Progress Note generated from a clinic visit with the treating physician or specialist no more than 90 days prior to the AME exam.
FAA source: CACI – Asthma Worksheet. FAA date 24 September 2025; checked by Crosscheck 14 October 2026.
Treating physician finds the condition stable on current regimen and no changes recommended.
FAA source: CACI – Asthma Worksheet. FAA date 24 September 2025; checked by Crosscheck 14 October 2026.
Symptoms: Stable and well-controlled (either on or off medication)
Yes for all of the following:
Frequency of symptoms - no more than 2 days per week - Use of inhaled short-acting beta agonist (rescue inhaler) - no more than 2 times per week - Use of oral corticosteroids for exacerbations - no more than 2 times per year - In the last year:
FAA source: CACI – Asthma Worksheet. FAA date 24 September 2025; checked by Crosscheck 14 October 2026.
In the last year: o No in-patient hospitalizations o No more than 2 outpatient clinic/urgent care visits for exacerbations (with symptoms fully resolved).
FAA source: CACI – Asthma Worksheet. FAA date 24 September 2025; checked by Crosscheck 14 October 2026.
Step 2: Medications
The kinds the worksheet lists, and a short course of steroids during a flare-up.One or more of the kinds of asthma medication the worksheet lists.
Acceptable
- Inhaled long-acting beta agonist
- Inhaled short-acting beta agonist, such as albuterol
- Inhaled corticosteroid
- Leukotriene receptor antagonist, such as montelukast (Singulair)
- Not: Not monoclonal antibodies
A short course of steroids
- A short course of oral or IM steroids during a flare-up is acceptable
Your AME must caution you not to fly until the course of oral steroids is finished and you are free of symptoms.
Show the FAA's words: Medications
Acceptable Medications NOT acceptable for CACI: Monoclonal antibodies [ ] One or more of the following - Inhaled long-acting beta agonist - Inhaled short-acting beta agonist (e.g., albuterol) - Inhaled corticosteroid - leukotriene receptor antagonist, (e.g. montelukast [Singulair])
FAA source: CACI – Asthma Worksheet. FAA date 24 September 2025; checked by Crosscheck 14 October 2026.
A short course of oral or IM steroids during an exacerbation is acceptable. The AME must caution airman not to fly until course of oral steroids is completed and airman is symptom free.
FAA source: CACI – Asthma Worksheet. FAA date 24 September 2025; checked by Crosscheck 14 October 2026.
Step 3: Breathing test (spirometry)
Current within the last 90 days, the minimum results, and when it is not required.One question insideA breathing test (spirometry), current within the last 90 days.
The result
- 80% of predicted or higher
Not required if your only treatment is a short-acting beta agonist, such as albuterol, used as needed on one or two days a week.
Show the FAA's words: Breathing test (spirometry)
Spirometry is not required if the only treatment is PRN use on one or two days a week of a short-acting beta agonist (e.g., albuterol). [ ] Current within last 90 days [ ] FEV1 and FVC are both equal to or greater than 80% predicted before bronchodilators.
FAA source: CACI – Asthma Worksheet. FAA date 24 September 2025; checked by Crosscheck 14 October 2026.
What the examiner checks
It depends on which row of the FAA's table describes the case.
Row AExaminer issuesExaminer can issue
If the examiner can determine the pilot has no symptoms that would interfere with flight or safety related duties, the examiner issues and annotates this information in Block 60.
Row BWorksheetCACI
The table sends the examiner to the CACI worksheet for asthma, and says this requires a current, detailed clinical progress note and spirometry (a breathing test). The worksheet itself says spirometry is not required if the only treatment is PRN use on one or two days a week of a short-acting beta agonist (e.g., albuterol). The examiner issues with no time limitation when the pilot meets every criterion on the worksheet and is otherwise qualified, annotates the correct CACI statement in Block 60, and keeps the required supporting information on file.
Row CDefers to the FAASpecial Issuance
The examiner defers and sends the listed information to the FAA for a possible Special Issuance, and annotates the elements or findings in Item 60.
If the examiner defers
Show the FAA's words: what the examiner does on each row
- Row A · Examiner can issue
A history of childhood asthma that has resolved, asthma caused by a specific and avoidable trigger managed by avoidance and use of as needed (PRN) rescue inhaler, or exercise-induced bronchoconstriction (exercise-induced asthma) treated with as needed (PRN) rescue inhaler only. If the examiner can determine the pilot has no symptoms that would interfere with flight or safety related duties, the examiner issues and annotates this information in Block 60.
History of childhood asthma, resolved OR Asthma caused by a specific and avoidable trigger (e.g. exposure to pet or animal dander, specific foods etc.) managed by avoidance and use of as needed (PRN) rescue inhaler OR Exercise-induced bronchoconstriction (a.k.a. exercise-induced asthma), treated with as needed (PRN) rescue inhaler only … If the AME can determine the individual has no symptoms that would interfere with flight or safety related duties: ISSUE … Annotate this information in Block 60.
- Row B · CACI
Intermittent or mild persistent asthma. The table sends the examiner to the CACI worksheet for asthma, and says this requires a current, detailed clinical progress note and spirometry (a breathing test). The worksheet itself says spirometry is not required if the only treatment is PRN use on one or two days a week of a short-acting beta agonist (e.g., albuterol). The examiner issues with no time limitation when the pilot meets every criterion on the worksheet and is otherwise qualified, annotates the correct CACI statement in Block 60, and keeps the required supporting information on file.
Intermittent or mild persistent … See the CACI -Asthma Worksheet. This requires a current, detailed Clinical Progress Note and spirometry. … If the pilot meets all CACI worksheet criteria and is otherwise qualified, ISSUE With no time limitation … Annotate the correct CACI statement in Block 60 and keep the required supporting information on file.
Spirometry is not required if the only treatment is PRN use on one or two days a week of a short-acting beta agonist (e.g., albuterol).
- Row C · Special Issuance
Moderate or severe persistent asthma. The examiner defers and sends the listed information to the FAA for a possible Special Issuance, and annotates the elements or findings in Item 60.
Moderate or Severe persistent … Submit the following for FAA review: … DEFER Submit the information to the FAA for a possible Special Issuance … Annotate (elements or findings) in Item 60.
The CACI worksheet's criteria
Progress note
What your treating physician finds
- Stable on the current treatment, with no changes recommended
- Symptoms stable and well controlled, on or off medication
The limits
- 2 a week or fewerDays with symptoms
- 2 times a week or fewerRescue inhaler use
- 2 times a year or fewerOral steroids for flare-ups
- NoneHospital stays in the last year
- 2 or fewer, fully resolvedClinic or urgent care visits for flare-ups in the last year
Your asthma medications
Acceptable
- Inhaled long-acting beta agonist
- Inhaled short-acting beta agonist, such as albuterol
- Inhaled corticosteroid
- Leukotriene receptor antagonist, such as montelukast (Singulair)
- Not: Not monoclonal antibodies
A short course of steroids
- A short course of oral or IM steroids during a flare-up is acceptable
Your AME must caution you not to fly until the course of oral steroids is finished and you are free of symptoms.
Breathing test (spirometry)
- 80% of predicted or higherFEV1 and FVC, before bronchodilators
Not required if your only treatment is a short-acting beta agonist, such as albuterol, used as needed on one or two days a week.
Show the FAA's words: the CACI worksheet's criteria for Asthma
- Stable on the current treatment, with no changes recommended
FAA criterion: the treating doctor finds the condition stable on the current treatment, with no changes recommended.
Treating physician finds the condition stable on current regimen and no changes recommended.
- Symptoms, rescue inhaler use and oral corticosteroid use
FAA criterion: symptoms stable and well-controlled (either on or off medication), with all of the following -- symptoms on no more than 2 days a week, a rescue inhaler (an inhaled short-acting beta agonist) no more than 2 times a week, oral corticosteroids for a flare-up (exacerbation) no more than 2 times a year, and the limits for the last year below.
Symptoms: Stable and well-controlled (either on or off medication) … Yes for all of the following: … Frequency of symptoms - no more than 2 days per week - Use of inhaled short-acting beta agonist (rescue inhaler) - no more than 2 times per week - Use of oral corticosteroids for exacerbations - no more than 2 times per year - In the last year:
- Hospital stays and urgent care visits in the last year
FAA criterion: in the last year, no hospital stays, and no more than 2 clinic or urgent care visits for flare-ups, with the symptoms fully resolved.
In the last year: o No in-patient hospitalizations o No more than 2 outpatient clinic/urgent care visits for exacerbations (with symptoms fully resolved).
- Medications from the kinds the worksheet lists
The worksheet's acceptable medications: one or more of the following -- an inhaled long-acting beta agonist, an inhaled short-acting beta agonist (e.g., albuterol), an inhaled corticosteroid, or a leukotriene receptor antagonist (e.g. montelukast [Singulair]). It names monoclonal antibodies as not acceptable for CACI.
Acceptable Medications NOT acceptable for CACI: Monoclonal antibodies [ ] One or more of the following - Inhaled long-acting beta agonist - Inhaled short-acting beta agonist (e.g., albuterol) - Inhaled corticosteroid - leukotriene receptor antagonist, (e.g. montelukast [Singulair])
- A short course of steroids during a flare-up
The worksheet notes that a short course of oral or IM steroids during a flare-up (exacerbation) is acceptable. It says the examiner must caution the pilot not to fly until the course of oral steroids is completed and the pilot is symptom free.
A short course of oral or IM steroids during an exacerbation is acceptable. The AME must caution airman not to fly until course of oral steroids is completed and airman is symptom free.
- A breathing test (spirometry)
FAA criterion: a breathing test (spirometry) current within the last 90 days, with FEV1 and FVC both at 80 percent of predicted or higher before bronchodilators. The worksheet says spirometry is not required if the only treatment is PRN use on one or two days a week of a short-acting beta agonist (e.g., albuterol).
Spirometry is not required if the only treatment is PRN use on one or two days a week of a short-acting beta agonist (e.g., albuterol). [ ] Current within last 90 days [ ] FEV1 and FVC are both equal to or greater than 80% predicted before bronchodilators.
If the examiner defersSpecial Issuance
The disposition table has the examiner defer moderate or severe persistent asthma.
What the FAA lists to send
- Item 1. A current, detailed clinical progress note generated from a clinic visit with the treating pulmonologist (lung specialist) no more than 90 days before the exam. The disposition table says it must include a detailed summary of the history of the condition, current medications with dosage and any side effects, ophthalmological exam findings (the table's own words), the results of any testing, the diagnosis, the assessment and plan, the prognosis, and follow-up.
- Item 2. The disposition table says the clinical progress note must specifically include the disease course and severity including flare(s), hospitalizations or intubations, treatment history, duration of symptoms, how long the condition has been stable, if any upcoming treatment change is planned or expected, and whether the condition severity limits activities.
- Item 3. Pulmonary functions test (PFTs) performed within the past 90 days. The disposition table says PFTs must be both pre-and post-bronchodilator and include flow volume loops.
- Item 4. Copies of any other testing already done.
Show the FAA's words: if the examiner defers
When the examiner defers
- Reason 1
The disposition table has the examiner defer moderate or severe persistent asthma.
Moderate or Severe persistent … DEFER Submit the information to the FAA for a possible Special Issuance
What the FAA lists to send
- Item 1
A current, detailed clinical progress note generated from a clinic visit with the treating pulmonologist (lung specialist) no more than 90 days before the exam. The disposition table says it must include a detailed summary of the history of the condition, current medications with dosage and any side effects, ophthalmological exam findings (the table's own words), the results of any testing, the diagnosis, the assessment and plan, the prognosis, and follow-up.
A current, detailed Clinical Progress Note generated from a clinic visit with the treating Pulmonologist no more than 90 days before the AME exam. It must include: A detailed summary of the history of the condition; Current medications, dosage, and side effects (if any); Ophthalmological exam findings; Results of any testing performed; Diagnosis; Assessment and plan; Prognosis; and Follow-up.
- Item 2
The disposition table says the clinical progress note must specifically include the disease course and severity including flare(s), hospitalizations or intubations, treatment history, duration of symptoms, how long the condition has been stable, if any upcoming treatment change is planned or expected, and whether the condition severity limits activities.
2. The Clinical Progress note must specifically include: the disease course and severity including flare(s), hospitalizations or intubations, treatment history, duration of symptoms, how long the condition has been stable, if any upcoming treatment change is planned or expected; and does the condition severity limit activities.
- Item 3
Pulmonary functions test (PFTs) performed within the past 90 days. The disposition table says PFTs must be both pre-and post-bronchodilator and include flow volume loops.
Pulmonary functions test (PFTs) performed within the past 90 days. PFTs must be both pre-and post-bronchodilator and include flow volume loops.
- Item 4
Copies of any other testing already done.
Copies of any other testing already performed
After the FAA decides
AASIThe AASI sheet says an FAA physician makes the first decision and grants the Authorization. After that, the sheet says the examiner may reissue under the Authorization when the pilot provides what it lists.
Show the FAA's words: after the FAA decides
An FAA physician provides the initial certification decision and grants the Authorization in accordance with 14 CFR § 67.401. … AMEs may re-issue an airman medical certificate under the provisions of an Authorization if the applicant provides the following:
What a Special Issuance is
The Guide says an Authorization for Special Issuance, valid for a specified period, may be granted at the Federal Air Surgeon's discretion to a person who does not meet the established medical standards, if the person shows to the satisfaction of the Federal Air Surgeon that the duties authorized by the class of certificate applied for can be performed without endangering public safety during the period the Authorization would be in force.
How the FAA pathways workAt later examsAASI
- First and second class
- Every year
- Third class
- At each required exam
The worksheet says first- and second-class applicants must provide this information every year, and third-class applicants must provide it with each required exam.
Show the FAA's words: how often the FAA asks again
Applicants for first- or second- class must provide this information annually; applicants for third-class must provide the information with each required exam.
Under an FAA Authorization, the AASI sheet lists what the pilot brings for the examiner to reissue. That is the Authorization itself, a yearly, current, detailed clinical progress note from the treating pulmonologist (lung specialist) dated no more than 90 days before the exam, and pulmonary function testing, if deemed necessary, performed no more than 90 days before the exam. The sheet says the Authorization letter comes with attachments that specify the information the treating doctors must provide for the reissue determination.
Show the FAA's words: at later exams
AMEs may re-issue an airman medical certificate under the provisions of an Authorization if the applicant provides the following: An Authorization granted by the FAA; Annual, current, detailed Clinical Progress Note generated from a clinic visit with the treating pulmonologist no more than 90 days before the AME exam. … Pulmonary function testing, if deemed necessary, performed no more than 90 days before the AME exam. … The Authorization letter is accompanied by attachments that specify the information that treating physician(s) must provide for the re-issuance determination.
What AASI is
AASI stands for AME Assisted Special Issuance. The Guide describes it as a process that lets the examiner reissue a certificate under the provisions of an Authorization for Special Issuance, to an applicant who has a medical condition that is disqualifying under 14 CFR part 67.
How the FAA pathways workThe Authorization granted by the FAA
The AASI sheet's first item for a reissue is the Authorization the FAA granted.
Show the FAA's words: The Authorization granted by the FAA
An Authorization granted by the FAA;
A yearly progress note from the treating pulmonologist (lung specialist)
For a reissue the AASI sheet asks for an annual, current, detailed clinical progress note from a visit with the treating pulmonologist (lung specialist), dated no more than 90 days before the exam.
Show the FAA's words: A yearly progress note from the treating pulmonologist (lung specialist)
Annual, current, detailed Clinical Progress Note generated from a clinic visit with the treating pulmonologist no more than 90 days before the AME exam.
What the progress note must include
The AASI sheet says the note must include a detailed interim summary; current medications, dosage and side effects, if any; physical exam findings; the results of all testing performed; the diagnosis; the assessment and plan (prognosis); and follow-up. It says the note must specifically include whether there has been any worsening in symptoms, hospitalizations, exacerbations, or inadequate compliance with treatment.
Show the FAA's words: What the progress note must include
It must include a detailed interim summary; current medications, dosage, and side effects (if any); physical exam findings; results of all testing performed; diagnosis; assessment and plan (prognosis); and follow-up. … It must specifically include if there has been any worsening in symptoms, hospitalizations, exacerbations, or inadequate compliance with treatment.
Lung function testing, if deemed necessary
The AASI sheet asks for pulmonary function testing, if it is deemed necessary, performed no more than 90 days before the exam.
Show the FAA's words: Lung function testing, if deemed necessary
Pulmonary function testing, if deemed necessary, performed no more than 90 days before the AME exam.
What the Authorization letter comes with
The AASI sheet says the Authorization letter comes with attachments that specify the information the treating doctors must provide for the reissue determination.
Show the FAA's words: What the Authorization letter comes with
The Authorization letter is accompanied by attachments that specify the information that treating physician(s) must provide for the re-issuance determination.
When the examiner defers a reissue
The AASI sheet says the examiner must defer recertification if there is a worsening of the condition, such as increased symptoms or an increase in the frequency of emergency room, hospital or outpatient visits; if the FEV1 is less than 70 percent of the predicted value; or if the pilot is taking steroid doses equivalent to more than 20 mg of prednisone per day.
Show the FAA's words: When the examiner defers a reissue
The AME must defer recertification if: There is a worsening of the condition such as increased symptoms or an increase in the frequency of emergency room, hospital, or outpatient visits; The FEV1 is less than 70% predicted value; or The applicant is taking steroid doses equivalent to more than 20 mg of prednisone per day
Good to know
Points from the FAA's own documents that are easy to miss.
What a progress note must include
In most cases it should come from a visit with the treating physician no more than 90 days ago, and cover the history, medications with dosages and side effects, exam findings, test results, diagnosis, assessment and plan, prognosis and follow-up. The FAA's sheet says to make sure the physician adds the prognosis. A portal note or an After Visit Summary that does not meet these criteria is not enough, and neither is a simple "ok to fly" letter. The FAA's documents also call it a status report.
Show the FAA's words: good to know, 1
your patient portal to print out “notes” or an “After Visit Summary (AVS).” … Patient Portal notes or an AVS that do not meet the criteria listed below for a detailed Clinical Progress Note are NOT sufficient for FAA purposes. … To be “current,” in MOST CASES, the detailed Clinical Progress Note should be from an evaluation in which you saw your treating physician no more than 90 days ago. … It Must include the following items: … A summary of the history of the condition, … Current medications, dosages, and side effects (if any); … Clinical exam findings; … Results of any testing performed; … Diagnosis; … Assessment and Plan; … Prognosis (This item may not be on a standard progress note, make sure your physician adds this information.); and … Follow-up … Please note: A letter stating, “Mr. Smith is ok to fly” (or any other simple note), is NOT a current, detailed Clinical Progress Note and is NOT acceptable. … You may also see this called a “current status report” or “status report” in current FAA Guidance. Any reference to a “status report” equals the criteria listed on this sheet.
A first AASI application is deferred
The AASI sheet says that for a first-time AASI application for this condition, with all the medical information needed for a determination, the examiner must defer and submit all of it to the AMCD or RFS for the initial determination.
Show the FAA's words: good to know, 2
If this is a first-time application for an AASI for the above disease/condition, and the applicant has all the requisite medical information necessary for a determination, the AME must defer and submit all of the documentation to the AMCD or RFS for the initial determination.
Three statements for Block 60
The examiner must note one of three in Block 60: CACI qualified asthma, where documents need not go to the FAA; has current or previous SI/AASI but now CACI qualified; or NOT CACI qualified, deferred, with supporting documents submitted.
Show the FAA's words: good to know, 3
AME MUST NOTE in Block 60 one of the following: … CACI qualified asthma. (Documents do not need to be submitted to the FAA.) … Has current OR previous SI/AASI but now CACI qualified asthma. … NOT CACI qualified asthma. I have deferred. (Submit supporting documents.)
The Item 35 page has its own table
The Guide's Item 35 page has its own two-row asthma table, for all classes. Mild or seasonal symptoms point to the CACI worksheet, issue if all criteria are met and all others an FAA decision; frequent severe symptoms do not. Both rows ask for all pertinent medical information and a current status report, an initial Special Issuance requires an FAA decision, and followups use the AASI protocol.
Show the FAA's words: good to know, 4
Item 35. Lungs and Chest – Asthma … Mild or seasonal asthmatic symptoms … All … Review all pertinent medical information and current status report, include PFT's, duration of symptoms, name and dosage of drugs and side effects for special issuance consideration … See CACI – Asthma Worksheet ( PDF ) . If airman meets all certification criteria – Issue . … All others require FAA Decision. Submit all evaluation data. … Initial Special Issuance – Requires FAA Decision … Followup Special Issuances – See AASI Protocol (PDF) … Frequent severe asthmatic symptoms … All … Submit all pertinent medical information and current status report, include PFT's, duration of symptoms, name and dosage of drugs and side effects … Initial Special Issuance – Requires FAA Decision … Followup Special Issuances – See AASI Protocol (PDF)
History of childhood asthma, resolved … Intermittent or mild persistent … Moderate or Severe persistent
Both papers have a 90-day limit
The worksheet's progress note is from a visit with the treating physician or specialist no more than 90 days before the exam, and the spirometry is current within the last 90 days.
Show the FAA's words: good to know, 5
Clinical Progress Note generated from a clinic visit with the treating physician or specialist no more than 90 days prior to the AME exam. … Spirometry (previously PFT) … [ ] Current within last 90 days
FAA sources
Every FAA document this page relies on, with the FAA's own date and the date Crosscheck last read it. The documents to print open at the FAA, so they are always the FAA's current ones.
- Open to print: CACI – Asthma Worksheet, a PDF at the FAA, in a new tab
- Asthma Disposition TableOpen to print: Asthma Disposition Table, a PDF at the FAA, in a new tab
Special Issuance
- Open to print: AASI for Asthma, a PDF at the FAA, in a new tab
- Open at the FAA: Guide for Aviation Medical Examiners – Item 35. Lungs and Chest – Asthma, a page at the FAA, in a new tab
- Open at the FAA: Pilot Information – What a Detailed Clinical Progress Note must contain, a PDF at the FAA, in a new tab
Related conditions
Each has its own page, with what the FAA's documents say about it.
Medication guidance
Medications Crosscheck lists as taken for asthma, each with its own page on what published FAA guidance says about it.
- Leukotriene receptor antagonist, asthma
This reports what the FAA has published. It is not medical advice, and it does not say how the FAA or an examiner will decide a case.